CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

NCT04162340 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

T Cell Lymphoma in Relapse
Refractory T-Cell Lymphoma

Interventions

BIOLOGICAL: CD4 CAR T cells

Sponsor

iCell Gene Therapeutics

Collaborators

[object Object]
[object Object]